You are here: Industry Insights > acquisition

News List

Bausch Health Acquires Eton’s M-100 Investigational Eye Drop americanpharmaceuticalreview
February 20, 2019
Bausch Health Companies and Bausch + Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton Pharmaceuticals announced a subsidiary of Bausch Health has acquired the U.S. rights to Eton Pharmaceuticals' EM-100.....
Lilly closes $8bn Loxo Oncology acquisition pharmaceutical-technology
February 19, 2019
Eli Lilly has completed the acquisition of all outstanding shares of Loxo Oncology in a deal valued at approximately $8bn, boosting its oncology portfolio with precision medicines to potentially treat genomically defined cancers.
Bharat Biotech acquires Chiron Behring Vaccines biospectrumasia
February 18, 2019
Bharat Biotech will acquire 100% equity stake in Chiron Behring Vaccines in an all cash transaction.
Johnson & Johnson to Acquire Auris Health americanpharmaceuticalreview
February 15, 2019
Johnson & Johnson announced that Ethicon entered into a definitive agreement to acquire Auris Health for approximately $3.4 billion in cash....
Aurobindo acquires Apotex’s operations in five European countries expressbpd
February 12, 2019
The company had inked a binding agreement on July 14, 2018
Hitachi to acquire apceth Biopharma biospectrumasia
February 02, 2019
This acquisition is expected to close in April 2019
GSK closes $5.1bn Tesaro acquisition pharmaceutical-technology
January 24, 2019
GlaxoSmithKline (GSK) has completed its acquisition of US-based biopharmaceutical company Tesaro for an aggregate cash consideration of $5.1bn....
Takeda mulling sale of emerging market drugs – report pharmaphorum
January 23, 2019
Takeda could be considering selling some emerging-market drugs in a bid to cut debts following its merger with Shire that completed earlier this month, according to a press report.
Emerging markets drugs worth $3B could be next on Takeda’s chopping board: report fiercepharma
January 22, 2019
Looking to trade in some assets outside Japan to fund its $58 billion takeover of Shire, Takeda is reportedly eyeing a sale of some emerging-market drugs it gained in another acquisition eight years ago.
AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals pharmafocusasia
January 21, 2019
AMAG Pharmaceuticals, Inc. announced today that it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical company....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page